Assessing for Erosion Stage During 5-Fluorouracil Therapy
Monitor the treated lesion for a predictable inflammatory sequence: erythema → vesiculation → desquamation → erosion → re-epithelialization, and terminate 5-FU application once the erosion stage is reached.
Clinical Assessment Algorithm
The erosion stage represents the therapeutic endpoint for 5-FU treatment of actinic keratoses and should be assessed through direct visual inspection of the treated area 1.
Expected Progression Sequence
When 5-FU is applied to a lesion, you should observe the following stages in order 1:
- Erythema (redness) - initial inflammatory response
- Vesiculation (blister formation) - typically follows erythema
- Desquamation (peeling/scaling)
- Erosion (loss of epidermis with exposed dermis) - THIS IS YOUR ENDPOINT
- Re-epithelialization (healing phase after stopping treatment)
Treatment Duration Guidance
For actinic keratoses: Apply 5-FU cream twice daily until the inflammatory response reaches the erosion stage, typically 2-4 weeks 1. Complete healing may not be evident for 1-2 months following cessation of therapy 1.
Critical timing consideration: Treatment duration significantly impacts outcomes. Studies show that treatment for ≥4 weeks achieves 93.2% complete clinical response, compared to only 57.1% for <2 weeks of treatment 2. However, you should still stop at erosion regardless of timeline.
Key Clinical Pitfalls
Do Not Confuse Erosion with Earlier Stages
- Erythema alone is insufficient - this is just initial inflammation
- Desquamation (scaling/peeling) precedes erosion but is not the endpoint
- True erosion shows exposed dermis with loss of the epithelial surface, often with oozing, crusting, and soreness 3
Site-Specific Cautions
Poor healing sites (especially lower legs): Exercise extreme caution and consider closer supervision 4, 3. The inflammatory response may be more severe and healing prolonged at these locations.
Hyperkeratotic lesions: If thick keratin overlies the lesion, 5-FU may not penetrate adequately 5. Consider pretreatment with keratolytics or alternative approaches if the expected inflammatory sequence does not develop.
Managing the Erosion Stage
Once erosion is identified:
- Immediately discontinue 5-FU application 1
- Inform the patient that healing will occur over the subsequent 1-2 months
- Emollients may be applied during the healing phase
- If excessive reaction occurs, weak topical steroids can be used 3
When Erosion Doesn't Occur
If after 4 weeks of twice-daily application you observe only erythema or mild desquamation without progression to erosion, consider:
- Poor drug penetration (hyperkeratotic lesions)
- Inadequate application technique
- Need for treatment intensification or alternative therapy
The erosion stage is both a clinical marker of adequate treatment and a signal to stop therapy to allow healing 1.